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Study Objectives:

Results:

Pain reduction or elimination in pediatric patients is a national standard of
care. Most hospitals apply a topical anesthetic to potential venipuncture
locations to alleviate pain and anticipatory anxiety of the procedure.
Unfortunately, available topical anesthetics formulations require 30-60
minutes application dwell time prior to venipuncture and vasoconstrictive
effects may differ between creams. Liposomal lidocaine cream has been
shown to reduce or eliminate pain after dwelling for 30 minutes. However,
in children who present with an acute illness, 30 minutes can be an
unacceptable wait time. The effectiveness of applying liposomal lidocaine
cream under occlusion for 15 minutes in urgent venipuncture has never
been studied. The objective was to determine if a liposomal lidocaine
cream that dwells for 15 minutes, versus the recommended 30 minutes,
decreases pain and anxiety in pediatric patients.

A total of 120 subjects were enrolled in the study, resulting in 57 subjects
enrolled into each group, and six subjects who were treatment failures.
Baseline characteristics did not differ (p > 0.05) between children in
the study and placebo groups. However, one interesting difference
that approached significance was that children in the study group had
experienced more venipuncture needlesticks in the past two years (M =
6.8, SD = 15.0) than the placebo group (M = 2.8, SD = 3.7, t(63) = -1.97, p
= 0.054). The relative risk of a painful venipuncture stick was 1.2, or 20%
greater (95% confidence interval 0.77 to 1.90) in the placebo group than the
study group. There were no significant differences in mean levels of patient,
parent or observer ratings of procedural anxiety, or patient heart rate or the
patient’s mean rating of venipuncture pain between the study and placebo
groups (p > 0.05). There were no significant differences in mean pain ratings
(p > 0.05) when data were grouped by patient age ranges (< 7 years, 7-11
years, 12-18 years).

Methods:
A prospective, randomized, double blind, placebo control study design
was used in which subjects were randomly assigned to receive either
liposomal lidocaine or placebo cream. The study population included
pediatric patients ages 5-18 years old, meeting the study criteria and who
presented to one site of a multi-site, academic, community Emergency
Department (ED). Once subjects were consented and enrolled in the study,
the liposomal lidocaine or a placebo cream was applied for 15 minutes
under occlusion. A 100mm Visual Analogue Scale (VAS) was used to
measure both perceived and observed level of parental and patient anxiety
before, during and after the venipuncture. A 6-point validated FACES pain
scale and heart rate (as an indirect measure) was used to rate patient level
of pain during venipuncture. History of previous venipuncture, difficulty
of venipuncture, and uniformity of topical ointment application were
documented.

Conclusions:
Application of liposomal lidocaine prior to venipuncture did show a small
reduction in relative risk of patient perceived venipuncture pain, but did not
reduce the mean level of patient perceived pain during venipuncture. No
differences in mean levels of procedural anxiety rating, patient heart rate, or
mean venipuncture pain rating was observed between study groups.

